Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
Crossref DOI link: https://doi.org/10.1007/s40273-014-0236-9
Published Online: 2014-11-18
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mensch, Alexander
Stock, Stephanie
Stollenwerk, Björn
Müller, Dirk
Text and Data Mining valid from 2014-11-18